News Releases

Select year
Categories

Myriad Genetics Announces Precise MRD Clinical Data Published in The Lancet Oncology

Sep 04, 2025 | Products

Read more

New Meta-Analysis Demonstrates that Access to the GeneSight Test Can Significantly Improve Response and Remission Rates for Patients with Depression

Sep 03, 2025 | Products

Read more

New Myriad Genetics Survey Uncovers Women Fear Screenings—But Feel Reassured by the Results

Aug 13, 2025 | Products

Read more

Myriad Genetics Announces Early Access to the FirstGene Multiple Prenatal Screen

Jun 03, 2025 | Products

Read more

Myriad Genetics Shares New Clinical Data Demonstrating Sensitivity of Precise MRD Across Multiple Cancer Types

Jun 02, 2025 | Products

Read more

Myriad Genetics Highlights New Research Advancements and Oncology Innovations at 2025 ASCO Annual Meeting

May 27, 2025 | Products | Pipeline

Read more

Myriad Genetics Announces RiskScore Study Published in JCO Precision Oncology

May 07, 2025 | Products

Read more

Concerns about Mental Health Medication Side Effects Remain a Barrier to Getting Help for Those Diagnosed with Depression and Anxiety, According to the GeneSight Mental Health Monitor

Apr 30, 2025 | Products

Read more

Myriad Genetics Highlights MRD Clinical Validity Data at American Association for Cancer Research Annual Meeting

Apr 25, 2025 | Products

Read more

Myriad Genetics Announces Study Results Show Patients with Depression had Fewer Psychiatric Hospitalizations after GeneSight Testing

Apr 21, 2025 | Products

Read more

Myriad Genetics and Gabbi to Work Together to Increase Access to Hereditary Cancer Risk Assessment Tools

Feb 27, 2025 | Products

Read more

Myriad Genetics Partners with PATHOMIQ to add Artificial Intelligence Technology Platform to its Oncology Portfolio

Feb 24, 2025 | Corporate | Pipeline | Products

Read more

Myriad Genetics and CancerCARE for Life Announce Agreement to Advance Access to MyRisk with RiskScore Hereditary Cancer Test

Feb 06, 2025 | Products

Read more

Myriad Genetics and Lumea Collaborate to Enhance Access to the Prolaris Biomarker and MyRisk Hereditary Cancer Tests through BxLink Integration

Feb 05, 2025 | Products

Read more

Myriad Genetics Unveils Groundbreaking Eight Weeks’ Gestation NIPT Study Results at Society for Maternal-Fetal Medicine Conference

Jan 29, 2025 | Products

Read more

Myriad Genetics Introduces Online Prenatal Genetic Testing Resource

Jan 23, 2025 | Products

Read more

Myriad Genetics Announces Hereditary Cancer Risk Assessment Program Study Published in Obstetrics & Gynecology

Jan 21, 2025 | Products | Corporate

Read more

Myriad Genetics Signs Agreement with Nationally Renowned Sports Broadcaster Hannah Storm to Promote the Importance of Knowing Family Cancer History

Jan 09, 2025 | Products | Corporate

Read more

MD Anderson and Myriad Genetics form strategic alliance to evaluate clinical utility of Myriad’s molecular residual disease assay

Jan 07, 2025 | Products | Corporate

Read more